 Home > Active Ingredient News > Antitumor Therapy > Gut: Can anti-hepatitis C virus treatment prevent liver cancer recurrence after liver cancer treatment?

Gut: Can anti-hepatitis C virus treatment prevent liver cancer recurrence after liver cancer treatment?

 Last Update: 2021-03-30
 Source: Internet
 Author: User

Tags

parainfluenza 3 treatment

11 16 plywood

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

After successful treatment of hepatocellular carcinoma (HCC), the benefits of direct-acting antiviral drugs (DAA) against hepatitis C virus (HCV) are still controversial.

This study aims to conduct a meta-analysis of individual patient data to assess the risk of liver cancer recurrence after taking DAA in these patients .

Assess the risk of liver cancer recurrence in these patients after taking DAA

Data from 977 patients from 21 HCV-related cirrhosis and HCC studies were included.

HCC recurrence risk/100 person-years

The recurrence rate and death risk of patients in the DAA group were 20/100 person-years (95%CI 13.

Among patients with matching propensity scores, there was no significant difference in RR between the exposed group and the non-exposed group (RR=0.

The impact of DAA exposure on the risk of liver cancer recurrence is uncertain

Original source:

Sapena Victor, Enea Marco, Torres Ferran et al.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Dacarbazine CAS 4342-03-4 for Scientific Research Chemical Reagents Use only

CAS No.: 4342-03-4

Pharmacy Grade

$4-5/G FOB

Lapatinib 99% white powder CAS231277-92-2 bulk Lapatinib

CAS No.: 231277-92-2

Pharmacy Grade

$88-98/KG FOB

Mitomycin C

CAS No.: 50-07-7

Industrial Grade

$0.1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.